,28,48,49,50 Our results support this scenario where higher NORAD levels are associated with an aggressive breast cancer subtype (TNBC) and poor relapse-free survival of patients, while NORAD KD inhibits cancer cell viability and migration. The gene discussed is NORAD; the disease is breast carcinoma.